Elucent Medical, a medical device company based in Eden Prairie, has appointed Jason Pesterfield as its president and CEO, and Kirk G. Jacquay as its chief financial officer.
Both executives join Elucent from Optellum Ltd., a startup medical technology AI software company using AI to predict lung cancer based on a single CT scan. Elucent Medical specializes in developing surgical navigation solutions to improve patient clinical outcomes. Its products include the EnVisio Navigation System, which was cleared by the FDA in 2019 and has been used in over 7,500 breast cancer patients. The system is designed to enhance precision and safety during surgery by guiding surgeons through the excision of targeted soft tissue and margins using the safest and most cosmetic pathway possible.
